Impact of extended endocrine therapy for patients with risk factors for late recurrence in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after 5 years of endocrine therapy

  1. Masahiro Ito
  2. Masakazu Amari
  3. Akiko Sato
  4. Masahiro Hikichi
  5. Natsuko Tsurumi
  6. Hinano Otofuji
  7. Shigehira Saji
Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1007/s10549-024-07509-1
  2. Version published to 10.21203/rs.3.rs-4960309/v1 on Research Square